Literature DB >> 19779137

Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping.

Zuzana Sisková1, Anton Page, Vincent O'Connor, Victor Hugh Perry.   

Abstract

A growing body of evidence suggests that the loss of synapses is an early and major component of a number of neurodegenerative diseases. Murine prion disease offers a tractable preparation in which to study synaptic loss in a chronic neurodegenerative disease and to explore the underlying mechanisms. We have previously shown that synaptic loss in the hippocampus underpins the first behavioral changes and that there is a selective loss of presynaptic elements. The microglia have an activated morphology at this stage but they have an anti-inflammatory phenotype. We reasoned that the microglia might be involved in synaptic stripping, removing synapses undergoing a degenerative process, and that this gives rise to the anti-inflammatory phenotype. Analysis of synaptic density revealed a progressive loss from 12 weeks post disease initiation. The loss of synapses was not associated with microglia processes; instead, we found that the postsynaptic density of the dendritic spine was progressively wrapped around the degenerating presynaptic element with loss of subcellular components. Three-dimensional reconstructions of these structures from Dual Beam electron microscopy support the conclusion that the synaptic loss in prion disease is a neuron autonomous event facilitated without direct involvement of glial cells. Previous studies described synapse engulfment by developing and injured neurons, and we suggest that this mechanism may contribute to developmental and pathological changes in synapse numbers.

Entities:  

Mesh:

Year:  2009        PMID: 19779137      PMCID: PMC2751557          DOI: 10.2353/ajpath.2009.090372

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  68 in total

Review 1.  Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles.

Authors:  M M Mesulam
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  A critical role for myosin IIb in dendritic spine morphology and synaptic function.

Authors:  Jubin Ryu; Lidong Liu; Tak Pan Wong; Dong Chuan Wu; Alain Burette; Richard Weinberg; Yu Tian Wang; Morgan Sheng
Journal:  Neuron       Date:  2006-01-19       Impact factor: 17.173

3.  An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease.

Authors:  Z Chiti; O M Knutsen; S Betmouni; J R T Greene
Journal:  Neurobiol Dis       Date:  2006-01-23       Impact factor: 5.996

4.  Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus.

Authors:  M Jeffrey; W G Halliday; J Bell; A R Johnston; N K MacLeod; C Ingham; A R Sayers; D A Brown; J R Fraser
Journal:  Neuropathol Appl Neurobiol       Date:  2000-02       Impact factor: 8.090

5.  Early loss of dendritic spines in murine scrapie revealed by confocal analysis.

Authors:  D Brown; P Belichenko; J Sales; M Jeffrey; J R Fraser
Journal:  Neuroreport       Date:  2001-01-22       Impact factor: 1.837

6.  Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes.

Authors:  M Jeffrey; S Martin; J Barr; A Chong; J R Fraser
Journal:  J Comp Pathol       Date:  2001-01       Impact factor: 1.311

7.  Dendritic and synaptic alterations of hippocampal pyramidal neurones in scrapie-infected mice.

Authors:  P V Belichenko; D Brown; M Jeffrey; J R Fraser
Journal:  Neuropathol Appl Neurobiol       Date:  2000-04       Impact factor: 8.090

8.  Interaction of the postsynaptic density-95/guanylate kinase domain-associated protein complex with a light chain of myosin-V and dynein.

Authors:  S Naisbitt; J Valtschanoff; D W Allison; C Sala; E Kim; A M Craig; R J Weinberg; M Sheng
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 9.  New insights into prion structure and toxicity.

Authors:  David A Harris; Heather L True
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

10.  TGFbeta1 regulates the inflammatory response during chronic neurodegeneration.

Authors:  Delphine Boche; Colm Cunningham; Fabian Docagne; Helen Scott; V Hugh Perry
Journal:  Neurobiol Dis       Date:  2006-02-28       Impact factor: 5.996

View more
  53 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Microdissection and transcriptional profiling: a window into the pathobiology of preclinical prion disease.

Authors:  Anna Majer; Stephanie A Booth
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

Review 3.  The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS.

Authors:  Dorothy P Schafer; Emily K Lehrman; Beth Stevens
Journal:  Glia       Date:  2012-07-24       Impact factor: 7.452

Review 4.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

5.  Death Receptor 6 and Caspase-6 Regulate Prion Peptide-Induced Axonal Degeneration in Rat Spinal Neurons.

Authors:  Yunsheng Wang; Deming Zhao; Bo Pan; Zhiqi Song; Syed Zahid Ali Shah; Xiaomin Yin; Xiangmei Zhou; Lifeng Yang
Journal:  J Mol Neurosci       Date:  2015-04-22       Impact factor: 3.444

Review 6.  The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective.

Authors:  V Hugh Perry; Vincent O'Connor
Journal:  ASN Neuro       Date:  2010-10-14       Impact factor: 4.146

7.  Synaptic protection in the brain of WldS mice occurs independently of age but is sensitive to gene-dose.

Authors:  Ann K Wright; Thomas M Wishart; Cali A Ingham; Thomas H Gillingwater
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

8.  Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Dennisse Gonzalez-Romero; Kristi Green; Giulio Taglialatela; Claudio Soto
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

9.  Plasma membrane invaginations containing clusters of full-length PrPSc are an early form of prion-associated neuropathology in vivo.

Authors:  Susan F Godsave; Holger Wille; Jason Pierson; Stanley B Prusiner; Peter J Peters
Journal:  Neurobiol Aging       Date:  2013-06       Impact factor: 4.673

10.  Silencing synapses: a route to understanding synapse degeneration in chronic neurodegenerative disease.

Authors:  Matteo Caleo; Laura Restani; V Hugh Perry
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.